Adjuvant transarterial chemoembolization was associated with improved outcomes in patients with hepatocellular carcinoma and microvascular invasion, but tumor size affected efficacy. | Read More
Artificial intelligence (AI) is the future of clinical data management with the potential to aid in the intersection between complex data and clinical decision making. Given AIs ability to rapidly analyze big data, interventional radiologists can design more individualized staging systems by collaborating to develop large highly organized multi-institutional registries thus improving how medicine is practiced, according to a recently published article. | Read More
At the time of percutaneous transhepatic portal vein embolization (PVE), hyperbilirubinemia has no apparent effect on future liver remnant (FLR) hypertrophy, according to a new study. | Read More
In this video, Sean M. Tutton, MD, FSIR discusses the 5 P’s of MSK interventions and the importance of remembering the mnemonic device “Prior Planning Prevents Poor Performance.” | Read More
Transcatheter arterial chemoembolization (TACE) combined with apatinib prolonged time to progression and overall survival compared to TACE-alone for Barcelona Clinic Liver Cancer stage C HCC, according to a study published in BMC Cancer. | Read More

Spotlight

In this video, Sean M. Tutton, MD, FSIR discusses the 5 P’s of MSK interventions and the importance of remembering the mnemonic device “Prior Planning Prevents Poor Performance.”
Ablation and stereotactic body radiation therapy are both effective treatments for patients with hepatocellular carcinoma, especially those in early stages of the disease. Siddharth A. Padia, MD explains what interventional radiologists need to know when deciding between ablation and SBRT for HCC.
In this video, Matthew Callstrom, MD, PhD discusses the risk of collecting system injury with microwave ablation and how central renal tumors can be effectively treated.